Matthew McAviney

Matthew McAviney

Director/Board Member at
Jamanda Ltd.
Finance
Consumer Services
Health Technology

Profile

Matthew McAviney is currently Director at Jamanda Ltd., Non-Executive Director at AviadoBio Ltd., and Partner at Monograph Capital Advisors (UK) LLP starting in 2026.
Formerly, Dr. McAviney was Director at Polyneuron Pharmaceuticals AG; Partner at NEA Management Co. LLC from 2018 to 2026; Principal at F-Prime, Inc. from 2013 to 2018; Senior Equity Research Associate & Biotechnology at Robert W.
Baird & Co., Inc. (Broker) from 2011 to 2012; and Associate, Health & Life Sciences Practice at Oliver, Wyman & Co. LLC from 2012 to 2013.
Education includes an undergraduate degree from The University of Chicago in 2006, a doctorate from the University of Illinois in 2011, and an MBA from the University of Chicago Booth School of Business in 2011.

Matthew McAviney active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -
Private Equity Investor 01/04/2026

Former positions of Matthew McAviney

CompaniesPositionEnd
Private Equity Investor 31/03/2026
Private Equity Investor 01/06/2018
Oliver, Wyman & Co. LLC
Private Equity Analyst 01/09/2013
Private Equity Analyst 01/08/2012
Director/Board Member -
See the detail of Matthew McAviney's experience

Training of Matthew McAviney

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

98

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Finance

Finance

Consumer Services

Consumer Services

Oliver, Wyman & Co. LLC

Finance

Health Technology

Finance

Health Technology

Finance

  1. Stock Market
  2. Insiders
  3. Matthew McAviney
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!